{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:04:47Z","timestamp":1785542687253,"version":"3.56.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004755","name":"EMD Serono","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008978","name":"Philips Oral Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011676","name":"Elekta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K08 CA255574"],"award-info":[{"award-number":["K08 CA255574"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA16058"],"award-info":[{"award-number":["P30 CA16058"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.hoc.2022.02.007","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T05:16:28Z","timestamp":1652246188000},"page":"553-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Local Therapies in Advanced Colorectal Cancer"],"prefix":"10.1016","volume":"36","author":[{"given":"Kathryn E.","family":"Hitchcock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Romesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2022.02.007_bib1","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 3","key":"10.1016\/j.hoc.2022.02.007_bib2","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"Van Cutsem","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib3","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1200\/JCO.2016.72.1464","article-title":"Impact of recurrence and salvage surgery on survival after multidisciplinary treatment of rectal cancer","volume":"35","author":"Ikoma","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib4","first-page":"496","article-title":"The clinical correlation of an autopsy study of recurrent colorectal cancer","volume":"189","author":"Welch","year":"1979","journal-title":"Ann Surg"},{"key":"10.1016\/j.hoc.2022.02.007_bib5","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","article-title":"Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy","volume":"27","author":"Kopetz","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/bjs.5349","article-title":"Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population","volume":"93","author":"Manfredi","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.hoc.2022.02.007_bib7","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/annonc\/mds053","article-title":"Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)","volume":"23","author":"Ruers","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib8","first-page":"109","article-title":"Local treatment of unresectable colorectal liver metastases: results of a randomized Phase II Trial","volume":"2017","author":"Ruers","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hoc.2022.02.007_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.prro.2015.10.011","article-title":"Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastases","volume":"6","author":"Goodman","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib10","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S1470-2045(17)30457-6","article-title":"First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials","volume":"18","author":"Wasan","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib11","first-page":"1387","article-title":"Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study","volume":"32","author":"Fiorentini","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.hoc.2022.02.007_bib12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/bjs.1800770720","article-title":"Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases","volume":"77","author":"Hunt","year":"1990","journal-title":"Br J Surg"},{"key":"10.1016\/j.hoc.2022.02.007_bib13","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","article-title":"Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)","volume":"24","author":"Kemeny","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1200\/JCO.2000.18.2.243","volume":"18","author":"Lorenz","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1245\/s10434-016-5418-6","article-title":"Hepatic arterial infusion in combination with modern systemic chemotherapy is associated with improved survival compared with modern systemic chemotherapy alone in patients with isolated unresectable colorectal liver metastases: a case-control study","volume":"24","author":"Dhir","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"17","key":"10.1016\/j.hoc.2022.02.007_bib16","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1200\/JCO.2016.71.8346","article-title":"Perioperative hepatic arterial infusion pump chemotherapy is associated with longer survival after resection of colorectal liver metastases: a propensity score analysis","volume":"35","author":"Groot Koerkamp","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib17","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJM199912303412702","article-title":"Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer","volume":"341","author":"Kemeny","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hoc.2022.02.007_bib18","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.21037\/jgo.2019.08.06","article-title":"Hepatic metastasis from colorectal cancer","volume":"10","author":"Kow","year":"2019","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib19","first-page":"26","article-title":"Optimizing sequencing beyond disease progression after second-line therapy in metastatic colorectal cancer","volume":"13","author":"Mody","year":"2017","journal-title":"Am J Hematol Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00384-019-03386-z","article-title":"Lung metastasectomy after colorectal cancer: prognostic impact of resection margin on long term survival, a retrospective cohort study","volume":"35","author":"Davini","year":"2020","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.hoc.2022.02.007_bib21","doi-asserted-by":"crossref","first-page":"S1259","DOI":"10.21037\/jtd.2017.04.44","article-title":"Prognostic factors after pulmonary metastasectomy of colorectal cancers: a single-center experience","volume":"9","author":"Fournel","year":"2017","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.hoc.2022.02.007_bib22","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.athoracsur.2017.03.021","article-title":"Surgical outcome and prognostic stratification for pulmonary metastasis from colorectal cancer","volume":"104","author":"Okumura","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hoc.2022.02.007_bib23","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ejcts\/ezy388","article-title":"Prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer","volume":"55","author":"Renaud","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.hoc.2022.02.007_bib24","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/codi.15113","article-title":"Pulmonary metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients - control survival is much better than previously assumed","volume":"22","author":"Milosevic","year":"2020","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.hoc.2022.02.007_bib25","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1245\/s10434-012-2726-3","article-title":"Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis","volume":"20","author":"Gonzalez","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib26","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1093\/annonc\/mds100","article-title":"Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model","volume":"23","author":"Salah","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib27","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ejso.2018.03.011","article-title":"Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: a history of resected liver metastases worsens the prognosis","volume":"44","author":"Zabaleta","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib28","doi-asserted-by":"crossref","first-page":"103308","DOI":"10.1016\/j.critrevonc.2021.103308","article-title":"Prognostic value of KRAS mutation in patients undergoing pulmonary metastasectomy for colorectal cancer: A systematic review and meta-analysis","volume":"160","author":"Huang","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.hoc.2022.02.007_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1470-2045(08)70155-4","article-title":"Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)","volume":"9","author":"Lencioni","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib30","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/annonc\/mdv037","article-title":"Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases","volume":"26","author":"de Baere","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib31","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.21873\/anticanres.11621","article-title":"Dose escalation improves outcome in stereotactic body radiotherapy for pulmonary oligometastases from colorectal cancer","volume":"37","author":"Jingu","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.hoc.2022.02.007_bib32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13014-015-0546-x","article-title":"Clinical efficacy of stereotactic ablative radiotherapy for lung metastases arising from colorectal cancer","volume":"10","author":"Jung","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib33","first-page":"e211","article-title":"Radiosensitivity of colon and rectal lung oligometastasis treated with stereotactic ablative radiotherapy","volume":"16","author":"Kinj","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.hoc.2022.02.007_bib34","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ijrobp.2015.04.004","article-title":"Colorectal histology is associated with an increased risk of local failure in lung metastases treated with stereotactic ablative radiation therapy","volume":"92","author":"Binkley","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.hoc.2022.02.007_bib35","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1186\/s12885-018-4865-9","article-title":"A\u00a0matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hoc.2022.02.007_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.clon.2016.02.001","article-title":"Exploratory analysis on overall survival after either surgery or stereotactic radiotherapy for lung oligometastases from colorectal cancer","volume":"28","author":"Filippi","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.hoc.2022.02.007_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/ans.16383","article-title":"Meta-analysis of survival outcomes following surgical and non surgical treatments for colorectal cancer metastasis to the lung","volume":"91","author":"Ratnayake","year":"2020","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.hoc.2022.02.007_bib38","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/cncr.30424","article-title":"Clinical and genetic determinants of ovarian metastases from colorectal cancer","volume":"123","author":"Ganesh","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2022.02.007_bib39","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1007\/s10350-008-9235-2","article-title":"Adrenalectomy for clinically isolated metastasis from colorectal carcinoma: report of eight cases","volume":"51","author":"Mourra","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.hoc.2022.02.007_bib40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.suronc.2016.09.008","article-title":"Management of para-aortic lymph node metastasis in colorectal patients: A systemic review","volume":"25","author":"Wong","year":"2016","journal-title":"Surg Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib41","first-page":"108","article-title":"Changing patterns of bone and brain metastases in patients with colorectal cancer","volume":"5","author":"Sundermeyer","year":"2005","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.hoc.2022.02.007_bib42","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamaoncol.2019.0192","article-title":"Single-fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases: a randomized phase 2 trial","volume":"5","author":"Nguyen","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib43","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1245\/s10434-017-5897-0","article-title":"Short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical treatment in primary stage iv rectal cancer: long-term results of a phase ii study","volume":"24","author":"Bisschop","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib44","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/annonc\/mdt124","article-title":"Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer","volume":"24","author":"van Dijk","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib45","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1245\/s10434-016-5189-0","article-title":"Survival following resection of intra- and extra-hepatic metastases from colorectal cancer: a phase II trial","volume":"23","author":"Wei","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib46","doi-asserted-by":"crossref","first-page":"100049","DOI":"10.1016\/j.lanepe.2021.100049","article-title":"Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 finnish metastatic colorectal cancer patients (RAXO): a nationwide prospective intervention study","volume":"3","author":"Osterlund","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.hoc.2022.02.007_bib47","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2022.02.007_bib48","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET Phase II Randomized Trial","volume":"38","author":"Palma","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.adro.2018.09.001","article-title":"Stereotactic ablative radiation therapy for unresectable colorectal oligometastases","volume":"4","author":"Sutera","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib50","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib52","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1200\/JCO.20.02447","article-title":"Primary tumor resection plus chemotherapy versus chemotherapy alone for colorectal cancer patients with asymptomatic, synchronous unresectable metastases (JCOG1007; iPACS): a randomized clinical trial","volume":"39","author":"Kanemitsu","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib53","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1245\/s10434-015-4925-1","article-title":"Surgical resection preferences and perceptions among medical oncologists treating liver metastases from colorectal cancer","volume":"23","author":"Choti","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib54","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-200206000-00002","article-title":"Trends in long-term survival following liver resection for hepatic colorectal metastases","volume":"235","author":"Choti","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.hoc.2022.02.007_bib55","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.radonc.2018.06.035","article-title":"Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review","volume":"129","author":"Petrelli","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib56","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.hpb.2017.05.011","article-title":"Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases - a meta-analysis","volume":"19","author":"van Amerongen","year":"2017","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hoc.2022.02.007_bib57","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fonc.2019.01052","article-title":"Ablation or resection for colorectal liver metastases? a systematic review of the literature","volume":"9","author":"Kron","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.hbpd.2021.05.004","article-title":"Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: a systematic review and network meta-analysis","volume":"20","author":"Gavriilidis","year":"2021","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hoc.2022.02.007_bib59","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1245\/s10434-014-3817-0","article-title":"A\u00a0retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases","volume":"21","author":"Correa-Gallego","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2022.02.007_bib60","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1200\/JCO.2015.66.1181","article-title":"SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer","volume":"34","author":"van Hazel","year":"2016","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858822000077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858822000077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:17:43Z","timestamp":1760185063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858822000077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0889858822000077"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2022.02.007","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local Therapies in Advanced Colorectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2022.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}